The difference in prognosis of stage II and III colorectal cancer based on preoperative serum tumor markers

Background: Preoperative serum tumor markers have been widely used to predict prognosis in stage II and III colorectal cancer (CRC). However, few previous studies addressed the effect of increased preoperative numbers of tumor markers. Methods: Patients with stage II and III CRC who underwent curati...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Weiqiang, Sheng, Nengquan, Yan, Li, Chen, Hongqi, Gong, Jianfeng, He, Zhenghui, Zheng, Kaiwen, Chen, Zhaohuan, Wang, Yafang, Tan, Gewen, Xie, Lu, Wang, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636282/
https://www.ncbi.nlm.nih.gov/pubmed/31333793
http://dx.doi.org/10.7150/jca.31660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636282/
https://www.ncbi.nlm.nih.gov/pubmed/31333793
http://dx.doi.org/10.7150/jca.31660

Ejemplares similares